by Jordana Choucair | Nov 18, 2021 | Life Sciences
AstraZeneca released new clinical trial results showing that its antibody treatment is highly effective at preventing COVID-19 in people who may not respond well to vaccines. According to the trial, patients given a single injection of the treatment were 83 percent...
by Jordana Choucair | Nov 18, 2021 | Life Sciences
Moderna submitted a revised request for the FDA to authorize booster doses of its COVID-19 vaccine for all adults. The FDA could grant Moderna and Pfizer clearance as early as this week. If the CDC also signs off, every adult who was fully vaccinated with the...
by Jordana Choucair | Nov 18, 2021 | Latest News, Newsroom
Remarks given by Vikki Wachino, a senior advisor at Third Horizon Strategies, at the National Association of Medicaid Directors Fall Conference on November 15, 2021. When we picture childhood, we like to picture joy, laughter and learning. We envision young kids...
by Tym Rourke | Nov 17, 2021 | Blog, Latest News, Mental Health & Addiction
For years, individuals, families, communities, and systems impacted by the opioid epidemic have sought a deeper understanding of the root causes of the explosion of opioid use disorders and opioid-related overdose deaths in the U.S. Of the many influencing factors,...
by Jordana Choucair | Nov 17, 2021 | Payers
New data from a Cigna subsidiary indicates that leveraging behavioral health treatment can result in a positive return on investment (ROI) for health plan sponsors. According to the research, behavioral health treatment in an outpatient setting leads to fewer...
Recent Comments